64 results
8-K
EX-99.1
URGN
UroGen Pharma Ltd.
13 Aug 24
UroGen Pharma Ahead of Schedule to Complete UGN-102 NDA Submission and Reports 2024 Second Quarter Financial Results and Business Highlights
8:01am
for UGN-103 and UGN-104; UroGen’s goals and commercial focus; 2024 financial guidance; the estimated patient population and demographics for UTUC
8-K
EX-10.1
URGN
UroGen Pharma Ltd.
8 Aug 24
Departure of Directors or Certain Officers
4:30pm
: (a) to promote the Company’s mission, long term goals and targets; (b) to create appropriate incentives for the Company’s directors and officers with the aim … of aligning such directors’ and officers’ compensation with the Company’s mission and goals, taking into account, among other things, the compensation
8-K
EX-10.2
URGN
UroGen Pharma Ltd.
8 Aug 24
Departure of Directors or Certain Officers
4:30pm
Period of the Performance Goals).
(iii) A maximum of $3.0 million may be granted as a Performance Cash Award to any one Participant during any one … be based on the satisfaction of Performance Goals or other criteria) as the Board may deem appropriate. The vesting provisions of individual Options
8-K
EX-10.1
wyhdzl6i orv2lmbl84h
13 Jun 22
Departure of Directors or Certain Officers
4:55pm